Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Other Working Capital Changes (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Other Working Capital Changes for 16 consecutive years, with -$17141.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 108.2% to -$17141.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$836100.0 through Dec 2025, down 443.73% year-over-year, with the annual reading at -$836100.0 for FY2025, 443.73% down from the prior year.
  • Other Working Capital Changes hit -$17141.0 in Q4 2025 for Cumberland Pharmaceuticals, up from -$178936.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $4.8 million in Q4 2023 to a low of -$1.4 million in Q2 2022.
  • Historically, Other Working Capital Changes has averaged $90517.8 across 5 years, with a median of -$242297.5 in 2022.
  • Biggest YoY gain for Other Working Capital Changes was 822.73% in 2022; the steepest drop was 7487.79% in 2022.
  • Year by year, Other Working Capital Changes stood at -$400166.0 in 2021, then surged by 822.73% to $2.9 million in 2022, then surged by 65.19% to $4.8 million in 2023, then crashed by 95.62% to $209073.0 in 2024, then crashed by 108.2% to -$17141.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for CPIX at -$17141.0 in Q4 2025, -$178936.0 in Q3 2025, and -$346081.0 in Q2 2025.